Citi Trends' stock tumbles after apparel retailer swung to a much wider-than-expected loss, citing a 'more selective' customer base
Shares of Citi Trends Inc. (CTRN) plunged 12.9% in premarket trading Tuesday after the urban fashion apparel retailer reported that it swung to a much wider-than-expected fiscal third-quarter loss on sales that fell more than forecast, as a more selective customer navigates higher costs of living. The net loss for the quarter to Oct. 28 was $3.9 million, or 47 cents a share, after net income of $24.6 million, or $3.02 a share, in the year-ago period. Excluding nonrecurring items, the adjusted per-share loss of 54 cents was wider than the FactSet loss consensus of 17 cents. Sales declined 6.7% to $179.5 million, below the FactSet consensus of $186.2 million, as same-store sales fell 6.2% to miss expectations of a 5.4% decline. "Our primarily low-income customer base is being more selective and purchasing much closer to need as they navigate higher costs of living, a buying pattern further impacted by unseasonably warm weather throughout the quarter," said Chief Executive David Makuen. For fiscal 2023, the company now expects sales to be down in the mid-single digit percentage range, compared with previous guidance of negative mid-single digits to negative low-single digits. The stock has rallied 14.7% over the past three months through Monday, while the S&P 500 has gained 2.6%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-28-23 0711ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel in Earnings Season
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth